Jilin Yatai Biological Pharmaceutical

Jilin Yatai Biological Pharmaceutical is a China-based biotechnology company focused on the development, production, and commercialization of human vaccines. As a key subsidiary of the Jilin Yatai Group, the company operates a large-scale manufacturing base in Changchun that complies with national GMP standards. Its flagship product is a Vero cell-based rabies vaccine for human use, which maintains a significant market share within the Chinese domestic market. The company continues to expand its portfolio with clinical-stage candidates targeting influenza and pneumococcal infections. It integrates research, development, and production to address critical public health needs through advanced automated production lines.